Mechanistic explanation for the unique pharmacologic properties of receptor partial agonists-Reference-Cited by-同舟云学术

Mechanistic explanation for the unique pharmacologic properties of receptor partial agonists

Published:2005-04 Issue:3 Volume:59 Page:76-89
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhu Bao Ting

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference43 articles.

1. Xamoterol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use;Furlong;Drugs,1988

2. Novel anxiolytics that act as partial agonists at benzodiazepine receptors;Haefely;Trends Pharmacol Sci,1990

3. Selective β1-adrenoceptor partial agonist treatment for congestive heart failure;Shabetai;Cardiology,1990

4. Affinity and intrinsic activity in the theory of competitive inhibition;Ariëns;Arch Int Pharmacodynamie Therapie,1954

5. Affinity and intrinsic-activity in the theory of competitive inhibition. Part III. Homologous decamethonium-derivatives and succinylcholine esters;Ariëns;Arch Intern Pharmacodynamie Therapie,1954

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators;2024-01-08

2. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a Partial STING Agonist, Competes for Human STING Activation;2023-12-07

3. Stereochemistry-Driven Interactions of α,γ-Peptide Ligands with the Neuropeptide Y Y₄-Receptor;Journal of Medicinal Chemistry;2023-07-13

4. Drug targets and drug-target molecules;A Pharmacology Primer;2022

5. Combined Therapy of A1AR Agonists and A2AAR Antagonists in Neuroinflammation;Molecules;2021-02-23